| Literature DB >> 7973549 |
H Furrer1, J von Overbeck, P Jaeger, B Hess.
Abstract
Sulfadiazine-nephropathy and -nephrolithiasis were well known complications of high dose sulfadiazine therapy 50 years ago. In the last few years high dose sulfadiazine therapy has been widely used for treatment of toxoplasmic encephalitis in AIDS patients. As a consequence sulfadiazine-nephropathy and -nephrolithiasis have become increasingly common. We describe 2 patients with the typical picture of these complications. Therapy is based on the fact that the solubility of sulfadiazine and its acetylated metabolite are markedly improved at higher urine-pH levels. Urine alkalinization is also effective for prophylaxis during sulfadiazine treatment. We present our guidelines for prophylaxis and treatment of these complications.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7973549
Source DB: PubMed Journal: Schweiz Med Wochenschr ISSN: 0036-7672